SEC Form 4 · accession 0001144204-15-007159
Tonix Pharmaceuticals Holding Corp. · TNXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leland Gershell
Officer — Chief Financial Officer
Period of report
Feb 9, 2015
Accepted (ET)
Feb 9, 2015 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001430306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | Feb 9, 2015 | P | 5,000 | $5.85 | A | 17,860 | D |
Table II — derivative securities
No Table II lines on this filing.